VEGFB and heart failure: The transgene (TG), adenoviral-mediated (Ad) or adeno-associated virus (AAV) expression of VEGF-B used in the animal model of MI or heart failure is strong and long-term, and the safety and controllability of these vectors are controversial for practical application [32].